Previous close | 21.60 |
Open | 21.70 |
Bid | 21.90 x 180000 |
Ask | 21.95 x 180000 |
Day's range | 21.70 - 21.70 |
52-week range | 11.70 - 22.05 |
Volume | |
Avg. volume | 6 |
Market cap | 910.953M |
Beta (5Y monthly) | 1.66 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.22 |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 09 Dec 2015 |
1y target est | 34.19 |
Artivion (AORT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Key Insights Artivion will host its Annual General Meeting on 14th of May CEO Pat Mackin's total compensation includes...
Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced financial results for the first quarter ended March 31, 2024.